We are live on ! Find out more
Verition Fund Management

Verition Fund Management Portfolio holdings

AUM $15.4B
1-Year Est. Return 30.69%
This Fund
S&P 500
This Quarter Est. Return
+2%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$7.23B
AUM Growth
+$828M
Cap. Flow
-$307M
Cap. Flow %
-4.25%
Top 10 Hldgs %
10.7%
Holding
2,791
New
730
Increased
583
Reduced
470
Closed
679

Sector Composition

Rank Sector Weight
1 Financials 12.25%
2 Industrials 9.66%
3 Utilities 9.48%
4 Technology 8.06%
5 Healthcare 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLD
751
DELISTED
TopBuild
BLD
$1.25M 0.02%
6,001
-43,661
-88% -$8.44M
TXRH icon
752
Texas Roadhouse
TXRH
$13.5B
$1.24M 0.02%
11,507
+6,987
+155% +$715K
D icon
753
Dominion Energy
D
$60.8B
$1.24M 0.02%
22,237
-197,684
-90% -$11.6M
CHTR icon
754
Charter Communications
CHTR
$17.3B
$1.24M 0.02%
3,475
+1,642
+90% +$613K
OLLI icon
755
Ollie's Bargain Outlet
OLLI
$4.44B
$1.23M 0.02%
21,267
+16,917
+389% +$930K
RYAN icon
756
Ryan Specialty Holdings
RYAN
$5.72B
$1.23M 0.02%
+30,467
New +$1.25M
ALLY icon
757
PUT
Ally Financial
ALLY
$13.2B
$1.22M 0.02%
+48,000
New +$1.38M
VKTX icon
758
Viking Therapeutics
VKTX
$3.7B
$1.22M 0.02%
+73,443
New +$759K
EFOR
759
Everforth Inc
EFOR
$1.17B
$1.22M 0.02%
+14,711
New +$1.28M
MTN icon
760
Vail Resorts
MTN
$5.32B
$1.21M 0.02%
5,199
+1,048
+25% +$253K
RVTY icon
761
Revvity
RVTY
$12.6B
$1.21M 0.02%
9,091
+6,279
+223% +$827K
MDGL icon
762
Madrigal Pharmaceuticals
MDGL
$10.8B
$1.21M 0.02%
4,977
+2,798
+128% +$762K
CRSP icon
763
CRISPR Therapeutics
CRSP
$4.73B
$1.2M 0.02%
26,597
+21,474
+419% +$1.04M
CANO
764
DELISTED
Cano Health, Inc.
CANO
$1.2M 0.02%
13,209
+2,630
+25% +$357K
CDAQ
765
DELISTED
Compass Digital Acquisition Corp. Class A Ordinary Shares
CDAQ
$1.19M 0.02%
117,122
-57,619
-33% -$584K
SAFE
766
Safehold
SAFE
$1.16B
$1.19M 0.02%
40,640
-217,910
-84% -$10.9M
ALGM icon
767
Allegro MicroSystems
ALGM
$7.73B
$1.19M 0.02%
+24,867
New +$1.01M
ARCC icon
768
PUT
Ares Capital
ARCC
$13.5B
$1.19M 0.02%
65,200
+29,700
+84% +$561K
EBAY icon
769
eBay
EBAY
$50.6B
$1.19M 0.02%
26,733
+3,834
+17% +$176K
TAP icon
770
Molson Coors Class B
TAP
$7.79B
$1.18M 0.02%
22,864
-4,281
-16% -$222K
NCLH icon
771
Norwegian Cruise Line
NCLH
$8.51B
$1.18M 0.02%
87,485
+32,575
+59% +$488K
HLIT icon
772
Harmonic Inc
HLIT
$1.25B
$1.18M 0.02%
80,620
+26,564
+49% +$366K
EVA
773
DELISTED
Enviva Inc.
EVA
$1.18M 0.02%
+40,700
New +$1.66M
SYF icon
774
Synchrony
SYF
$24.7B
$1.17M 0.02%
+40,062
New +$1.35M
STT icon
775
State Street
STT
$50.6B
$1.16M 0.02%
15,362
-1,833
-11% -$154K

Similar funds

Verition Fund Management's Q1 2023 Portfolio in Review

As of Q1 2023, Verition Fund Management held 2,791 positions worth $7.23B, up 13% from $6.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Verition Fund Management withdrew a net $307M in Q1 2023, closing 679 positions and reducing 470 holdings. Its most notable exit was AstraZeneca, an estimated $38.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Utilities.

Against the trend, Verition Fund Management opened a new position in Jacobs Solutions worth $33.6M.

  • Verition Fund Management's largest Q1 2023 buy was Jacobs Solutions: 346,045 shares worth $33.6M.
  • Verition Fund Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $53M increase.
  • Verition Fund Management's biggest Q1 2023 reduction was US Bancorp, cutting an estimated $47.9M.
  • Verition Fund Management fully exited AstraZeneca in Q1 2023, selling an estimated $38.7M.
  • Verition Fund Management's ten largest holdings make up 11% of its $7.23B portfolio in Q1 2023.
  • Verition Fund Management opened 730 new positions and closed 679 in Q1 2023.
  • Verition Fund Management's portfolio value rose 13% quarter-over-quarter to $7.23B.

Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.